Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 95 articles:
HTML format



Single Articles


    January 2021
  1. KERN I, Schoffer O, Kiess W, Henker J, et al
    Incidence trends of pediatric onset inflammatory bowel disease in the years 2000-2009 in Saxony, Germany-first results of the Saxon Pediatric IBD Registry.
    PLoS One. 2021;16:e0243774.
    PubMed     Abstract available


  2. KONSTANTINIDIS AO, Adamama-Moraitou KK, Pardali D, Dovas CI, et al
    Colonic mucosal and cytobrush sample cytokine mRNA expression in canine inflammatory bowel disease and their correlation with disease activity, endoscopic and histopathologic score.
    PLoS One. 2021;16:e0245713.
    PubMed     Abstract available


  3. NAFTALI T, Bar-Lev Schleider L, Scklerovsky Benjaminov F, Konikoff FM, et al
    Cannabis is associated with clinical but not endoscopic remission in ulcerative colitis: A randomized controlled trial.
    PLoS One. 2021;16:e0246871.
    PubMed     Abstract available


  4. REVILLA L, Mayorgas A, Corraliza AM, Masamunt MC, et al
    Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis.
    PLoS One. 2021;16:e0246367.
    PubMed     Abstract available


  5. DING ZH, Xu XP, Wang TR, Liang X, et al
    The prevalence of Helicobacter pylori infection in inflammatory bowel disease in China: A case-control study.
    PLoS One. 2021;16:e0248427.
    PubMed     Abstract available


  6. RANA T, Korolkova OY, Rachakonda G, Williams AD, et al
    Linking bacterial enterotoxins and alpha defensin 5 expansion in the Crohn's colitis: A new insight into the etiopathogenetic and differentiation triggers driving colonic inflammatory bowel disease.
    PLoS One. 2021;16:e0246393.
    PubMed     Abstract available


  7. ARKTEG CB, Wergeland Sorbye S, Buhl Riis L, Dalen SM, et al
    Real-life evaluation of histologic scores for Ulcerative Colitis in remission.
    PLoS One. 2021;16:e0248224.
    PubMed     Abstract available


  8. TAMAN H, Fenton CG, Anderssen E, Florholmen J, et al
    DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis.
    PLoS One. 2021;16:e0248905.
    PubMed     Abstract available


  9. FURUSE M, Hosomi S, Nishida Y, Itani S, et al
    The impact of cytochrome P450 3A genetic polymorphisms on tacrolimus pharmacokinetics in ulcerative colitis patients.
    PLoS One. 2021;16:e0250597.
    PubMed     Abstract available


  10. XU F, Park S, Liu Y, Greenlund KJ, et al
    Dietary intake patterns among adults with inflammatory bowel disease in the United States, 2015.
    PLoS One. 2021;16:e0250441.
    PubMed     Abstract available


  11. ISHIDA N, Higuchi T, Miyazu T, Tamura S, et al
    Serum N-terminal telopeptide of type I collagen as a biomarker for predicting bone density loss in patients with Crohn disease.
    PLoS One. 2021;16:e0250658.
    PubMed     Abstract available


  12. BUSINGYE D, Pollack A, Chidwick K
    Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    PLoS One. 2021;16:e0252458.
    PubMed     Abstract available


  13. TREFZER R, Elpeleg O, Gabrusskaya T, Stepensky P, et al
    Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease.
    PLoS One. 2021;16:e0252428.
    PubMed     Abstract available


  14. YEN HH, Su PY, Huang SP, Wu L, et al
    Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study.
    PLoS One. 2021;16:e0252286.
    PubMed     Abstract available


  15. SMITH SCL, Banbury C, Zardo D, Cannatelli R, et al
    Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease.
    PLoS One. 2021;16:e0252210.
    PubMed     Abstract available


  16. CAPITANO ML, Jaiswal A, Broxmeyer HE, Pride Y, et al
    A humanized monoclonal antibody against the endothelial chemokine CCL21 for the diagnosis and treatment of inflammatory bowel disease.
    PLoS One. 2021;16:e0252805.
    PubMed     Abstract available


  17. KATO M, Sugimoto K, Ikeya K, Takano R, et al
    Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease.
    PLoS One. 2021;16:e0254548.
    PubMed     Abstract available


  18. ORFEI M, Gasparetto M, Hensel KO, Zellweger F, et al
    Guidance on the interpretation of faecal calprotectin levels in children.
    PLoS One. 2021;16:e0246091.
    PubMed     Abstract available


  19. MADARAME A, Fukuzawa M, Yamauchi Y, Kono S, et al
    Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase.
    PLoS One. 2021;16:e0255620.
    PubMed     Abstract available


  20. LEE JM, Jang JH, Ryu JH, Yoo J, et al
    A comparison of diagnostic performance between two quantitative rapid fecal calprotectin assays in detecting active inflammatory bowel disease.
    PLoS One. 2021;16:e0255974.
    PubMed     Abstract available


  21. GAN RW, Sun D, Tatro AR, Cohen-Mekelburg S, et al
    Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease.
    PLoS One. 2021;16:e0257520.
    PubMed     Abstract available


  22. ZHANG L, Wu YB, Dai YK, Liu Q, et al
    Efficacy and safety of Qingre-Chushi therapies in active ulcerative colitis: A network meta-analysis.
    PLoS One. 2021;16:e0257599.
    PubMed     Abstract available


  23. KARMI N, Bangma A, Spekhorst LM, van Dullemen HM, et al
    Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNFalpha therapy in inflammatory bowel disease.
    PLoS One. 2021;16:e0256860.
    PubMed     Abstract available


  24. AL-SADI R, Engers J, Haque M, King S, et al
    Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junction barrier is mediated by NF-kappaB activation.
    PLoS One. 2021;16:e0249544.
    PubMed     Abstract available


  25. CREEMERS RH, Rezazadeh Ardabili A, Jonkers DM, Leers MPG, et al
    Severe COVID-19 in inflammatory bowel disease patients in a population-based setting.
    PLoS One. 2021;16:e0258271.
    PubMed     Abstract available


  26. TAO F, Xing X, Wu J, Jiang R, et al
    Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice.
    PLoS One. 2021;16:e0248482.
    PubMed     Abstract available


  27. MEI Z, Feng Q, Du P, Li B, et al
    Surgical treatment for cryptoglandular and Crohn's perianal fistulas: Protocol of an umbrella review.
    PLoS One. 2021;16:e0251460.
    PubMed     Abstract available


  28. MORAN MM, Wessman P, Rolfson O, Bohl DD, et al
    The risk of revision following total hip arthroplasty in patients with inflammatory bowel disease, a registry based study.
    PLoS One. 2021;16:e0257310.
    PubMed     Abstract available


  29. BIN MASUD S, Jenkins C, Hussey E, Elkin-Frankston S, et al
    Utilizing machine learning with knockoff filtering to extract significant metabolites in Crohn's disease with a publicly available untargeted metabolomics dataset.
    PLoS One. 2021;16:e0255240.
    PubMed     Abstract available


  30. MIYAZAKI C, Katsumasa N, Huang KC, Liu YF, et al
    Evaluation of economic burden with biologic treatments in Crohn's disease patients: A mirror image study using an insurance database in Japan.
    PLoS One. 2021;16:e0254807.
    PubMed     Abstract available


  31. WILSON PA, Santos Franco S, He L, Galwey NW, et al
    Transcriptomic effects of rs4845604, an IBD and allergy-associated RORC variant, in stimulated ex vivo CD4+ T cells.
    PLoS One. 2021;16:e0258316.
    PubMed     Abstract available


  32. MARRIE RA, Walld R, Bolton JM, Sareen J, et al
    Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease.
    PLoS One. 2021;16:e0249809.
    PubMed     Abstract available


  33. PARK HT, Park WB, Kim S, Lim JS, et al
    Revealing immune responses in the Mycobacterium avium subsp. paratuberculosis-infected THP-1 cells using single cell RNA-sequencing.
    PLoS One. 2021;16:e0254194.
    PubMed     Abstract available


  34. WANG J, Bleich RM, Zarmer S, Zhang S, et al
    Long-read sequencing to interrogate strain-level variation among adherent-invasive Escherichia coli isolated from human intestinal tissue.
    PLoS One. 2021;16:e0259141.
    PubMed     Abstract available


  35. MORIKUBO H, Kobayashi T, Fukuda T, Nagahama T, et al
    Development of algorithms for identifying patients with Crohn's disease in the Japanese health insurance claims database.
    PLoS One. 2021;16:e0258537.
    PubMed     Abstract available


    January 2020
  36. ARMUZZI A, DiBonaventura MD, Tarallo M, Lucas J, et al
    Treatment patterns among patients with moderate-to-severe ulcerative colitis in the United States and Europe.
    PLoS One. 2020;15:e0227914.
    PubMed     Abstract available


  37. CIAPPONI A, Virgilio SA, Berrueta M, Soto NC, et al
    Epidemiology of inflammatory bowel disease in Mexico and Colombia: Analysis of health databases, mathematical modelling and a case-series study.
    PLoS One. 2020;15:e0228256.
    PubMed     Abstract available


  38. JODELEIT H, Milchram L, Soldo R, Beikircher G, et al
    Autoantibodies as diagnostic markers and potential drivers of inflammation in ulcerative colitis.
    PLoS One. 2020;15:e0228615.
    PubMed     Abstract available


  39. DANG X, Xu M, Liu D, Zhou D, et al
    Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0228846.
    PubMed     Abstract available


  40. YU TB, Dodd S, Yu LG, Subramanian S, et al
    Serum galectins as potential biomarkers of inflammatory bowel diseases.
    PLoS One. 2020;15:e0227306.
    PubMed     Abstract available


  41. LIM WW, Ng B, Widjaja A, Xie C, et al
    Transgenic interleukin 11 expression causes cross-tissue fibro-inflammation and an inflammatory bowel phenotype in mice.
    PLoS One. 2020;15:e0227505.
    PubMed     Abstract available


  42. KUBESCH A, Boulahrout P, Filmann N, Blumenstein I, et al
    Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort.
    PLoS One. 2020;15:e0227309.
    PubMed     Abstract available


  43. HAN MK, Anderson R, Viennois E, Merlin D, et al
    Examination of food consumption in United States adults and the prevalence of inflammatory bowel disease using National Health Interview Survey 2015.
    PLoS One. 2020;15:e0232157.
    PubMed     Abstract available


  44. YAMAMOTO-FURUSHO JK, Mendieta-Escalante EA
    Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis.
    PLoS One. 2020;15:e0231988.
    PubMed     Abstract available


  45. HAZLEWOOD GS, Pokharel G, Deardon R, Marshall DA, et al
    Patient preferences for maintenance therapy in Crohn's disease: A discrete-choice experiment.
    PLoS One. 2020;15:e0227635.
    PubMed     Abstract available


  46. BROKERHOF IM, Ybema JF, Bal PM
    Illness narratives and chronic patients' sustainable employability: The impact of positive work stories.
    PLoS One. 2020;15:e0228581.
    PubMed     Abstract available


  47. KUNOVSZKI P, Milassin A, Gimesi-Orszagh J, Takacs P, et al
    Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary - a population-based study.
    PLoS One. 2020;15:e0233238.
    PubMed     Abstract available


  48. MAVROPOULOU E, Mechie NC, Knoop R, Petzold G, et al
    Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study.
    PLoS One. 2020;15:e0233811.
    PubMed     Abstract available


  49. BURISCH J, Eigner W, Schreiber S, Aletaha D, et al
    Risk for development of inflammatory bowel disease under inhibition of interleukin 17: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0233781.
    PubMed     Abstract available


  50. ARAKI M, Shinzaki S, Yamada T, Arimitsu S, et al
    Psychologic stress and disease activity in patients with inflammatory bowel disease: A multicenter cross-sectional study.
    PLoS One. 2020;15:e0233365.
    PubMed     Abstract available


  51. PARK J, Yoon H, Shin CM, Park YS, et al
    Higher levels of disease-related knowledge reduce medical acceleration in patients with inflammatory bowel disease.
    PLoS One. 2020;15:e0233654.
    PubMed     Abstract available


  52. SCOVILLE EA, Tindle HA, Wells QS, Peyton SC, et al
    Precision nicotine metabolism-informed care for smoking cessation in Crohn's disease: A pilot study.
    PLoS One. 2020;15:e0230656.
    PubMed     Abstract available


  53. WANG J, Ortiz C, Fontenot L, Xie Y, et al
    High circulating elafin levels are associated with Crohn's disease-associated intestinal strictures.
    PLoS One. 2020;15:e0231796.
    PubMed     Abstract available


  54. ZHOU M, Xu R, Kaelber DC, Gurney ME, et al
    Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer's disease in patients with rheumatoid arthritis and psoriasis.
    PLoS One. 2020;15:e0229819.
    PubMed     Abstract available


  55. KANG EA, Chun J, Im JP, Lee HJ, et al
    Anemia is associated with the risk of Crohn's disease, not ulcerative colitis: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0238244.
    PubMed     Abstract available


  56. WIDBOM L, Schneede J, Midttun O, Ueland PM, et al
    Elevated plasma cotinine is associated with an increased risk of developing IBD, especially among users of combusted tobacco.
    PLoS One. 2020;15:e0235536.
    PubMed     Abstract available


  57. HALE LP
    Deficiency of activation-induced cytidine deaminase in a murine model of ulcerative colitis.
    PLoS One. 2020;15:e0239295.
    PubMed     Abstract available


  58. TABORELLI M, Sozzi M, Del Zotto S, Toffolutti F, et al
    Risk of intestinal and extra-intestinal cancers in patients with inflammatory bowel diseases: A population-based cohort study in northeastern Italy.
    PLoS One. 2020;15:e0235142.
    PubMed     Abstract available


  59. PARK A, Kim S, Jung IH, Byun JH, et al
    An immune therapy model for effective treatment on inflammatory bowel disease.
    PLoS One. 2020;15:e0238918.
    PubMed     Abstract available


  60. CALDEIRA LF, Borba HH, Tonin FS, Wiens A, et al
    Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis.
    PLoS One. 2020;15:e0238910.
    PubMed     Abstract available


  61. SCHNITZLER F, Friedrich M, Angelberger M, Diegelmann J, et al
    Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn's disease and active smoking status resulting in ileal stenosis requiring surgery.
    PLoS One. 2020;15:e0236421.
    PubMed     Abstract available


  62. CAI B, Zhou MH, Huang HL, Zhou AC, et al
    Protective effects of citrulline supplementation in ulcerative colitis rats.
    PLoS One. 2020;15:e0240883.
    PubMed     Abstract available


  63. ALLAIS L, Verschuere S, Maes T, De Smet R, et al
    Translational research into the effects of cigarette smoke on inflammatory mediators and epithelial TRPV1 in Crohn's disease.
    PLoS One. 2020;15:e0236657.
    PubMed     Abstract available


  64. NISHIDA Y, Hosomi S, Yamagami H, Fujimoto K, et al
    Novel prognostic biomarkers of pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: Neutrophil-to-lymphocyte ratio.
    PLoS One. 2020;15:e0241322.
    PubMed     Abstract available


  65. UCHIYAMA K, Takami S, Suzuki H, Umeki K, et al
    Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial.
    PLoS One. 2020;15:e0241337.
    PubMed     Abstract available


  66. HOFFMANN P, Behnisch R, Gsenger J, Schnitzler P, et al
    Hepatitis E seroprevalence in a German cohort of patients with inflammatory bowel diseases.
    PLoS One. 2020;15:e0239825.
    PubMed     Abstract available


  67. LIMSRIVILAI J, Lee CK, Prueksapanich P, Harinwan K, et al
    Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.
    PLoS One. 2020;15:e0242879.
    PubMed     Abstract available


  68. DOMENIS R, Marino M, Cifu A, Scardino G, et al
    Circulating exosomes express alpha4beta7 integrin and compete with CD4+ T cells for the binding to Vedolizumab.
    PLoS One. 2020;15:e0242342.
    PubMed     Abstract available


  69. LI LN, Liu Y, Zhang HC, Wu T, et al
    Helicobacter pylori infection reduces TAMs infiltration in a mouse model of AOM/DSS induced colitis-associated cancer.
    PLoS One. 2020;15:e0241840.
    PubMed     Abstract available


    January 2019
  70. THOMAS T, Chandan JS, Li VSW, Lai CY, et al
    Global smoking trends in inflammatory bowel disease: A systematic review of inception cohorts.
    PLoS One. 2019;14:e0221961.
    PubMed     Abstract available


  71. DEURING JJ, Li M, Cao W, Chen S, et al
    Pregnane X receptor activation constrains mucosal NF-kappaB activity in active inflammatory bowel disease.
    PLoS One. 2019;14:e0221924.
    PubMed     Abstract available


  72. PALMER NP, Silvester JA, Lee JJ, Beam AL, et al
    Concordance between gene expression in peripheral whole blood and colonic tissue in children with inflammatory bowel disease.
    PLoS One. 2019;14:e0222952.
    PubMed     Abstract available


  73. BATHE AL, Mavropoulou E, Mechie NC, Petzold G, et al
    Impact of faecal calprotectin measurement on clinical decision-making in patients with Crohn's disease and ulcerative colitis.
    PLoS One. 2019;14:e0223893.
    PubMed     Abstract available


  74. COLLIJ V, Imhann F, Vich Vila A, Fu J, et al
    SLC39A8 missense variant is associated with Crohn's disease but does not have a major impact on gut microbiome composition in healthy subjects.
    PLoS One. 2019;14:e0211328.
    PubMed     Abstract available


  75. VON MARTELS JZH, Bourgonje AR, Harmsen HJM, Faber KN, et al
    Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.
    PLoS One. 2019;14:e0211973.
    PubMed     Abstract available


  76. MATTHEWS SM, Eshelman MA, Berg AS, Koltun WA, et al
    The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells.
    PLoS One. 2019;14:e0212850.
    PubMed     Abstract available


  77. SAGAMI S, Kobayashi T, Kikkawa N, Umeda S, et al
    Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease.
    PLoS One. 2019;14:e0212404.
    PubMed     Abstract available


  78. GOLL R, Heitmann R, Moe OK, Carlsen K, et al
    Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis.
    PLoS One. 2019;14:e0224895.
    PubMed     Abstract available


  79. ATHERLY T, Rossi G, White R, Seo YJ, et al
    Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.
    PLoS One. 2019;14:e0226780.
    PubMed     Abstract available


  80. HAISMA SM, Galaurchi A, Almahwzi S, Adekanmi Balogun JA, et al
    Head-to-head comparison of three stool calprotectin tests for home use.
    PLoS One. 2019;14:e0214751.
    PubMed     Abstract available


  81. COLONETTI K, Bento Dos Santos B, Nalin T, Moura de Souza CF, et al
    Hepatic glycogen storage diseases are associated to microbial dysbiosis.
    PLoS One. 2019;14:e0214582.
    PubMed     Abstract available


  82. LI E, Zhang Y, Tian X, Wang X, et al
    Influence of Crohn's disease related polymorphisms in innate immune function on ileal microbiome.
    PLoS One. 2019;14:e0213108.
    PubMed     Abstract available


  83. ROBINSON SC, Chaudhary R, Jimenez-Saiz R, Rayner LGA, et al
    Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity.
    PLoS One. 2019;14:e0217220.
    PubMed     Abstract available


  84. KONDO K, Ohfuji S, Watanabe K, Yamagami H, et al
    The association between environmental factors and the development of Crohn's disease with focusing on passive smoking: A multicenter case-control study in Japan.
    PLoS One. 2019;14:e0216429.
    PubMed     Abstract available


  85. SAMARANI S, Mack DR, Bernstein CN, Iannello A, et al
    Activating Killer-cell Immunoglobulin-like Receptor genes confer risk for Crohn's disease in children and adults of the Western European descent: Findings based on case-control studies.
    PLoS One. 2019;14:e0217767.
    PubMed     Abstract available


  86. BON L, Scharl S, Vavricka S, Rogler G, et al
    Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study.
    PLoS One. 2019;14:e0215738.
    PubMed     Abstract available


  87. TALPIN A, Kattah MG, Advincula R, Fadrosh D, et al
    A20 in dendritic cells restrains intestinal anti-bacterial peptide expression and preserves commensal homeostasis.
    PLoS One. 2019;14:e0218999.
    PubMed     Abstract available


  88. MARKOTA A, Metzger R, Heiseke AF, Jandl L, et al
    Comparison of iron-reduced and iron-supplemented semisynthetic diets in T cell transfer colitis.
    PLoS One. 2019;14:e0218332.
    PubMed     Abstract available


  89. HOLOTA Y, Dovbynchuk T, Kaji I, Vareniuk I, et al
    The long-term consequences of antibiotic therapy: Role of colonic short-chain fatty acids (SCFA) system and intestinal barrier integrity.
    PLoS One. 2019;14:e0220642.
    PubMed     Abstract available


  90. ADLER J, Jary HK, Eder SJ, Dong S, et al
    Identifying perianal fistula complications in pediatric patients with Crohn's disease using administrative claims.
    PLoS One. 2019;14:e0219893.
    PubMed     Abstract available


  91. BOTTOMS L, Leighton D, Carpenter R, Anderson S, et al
    Affective and enjoyment responses to 12 weeks of high intensity interval training and moderate continuous training in adults with Crohn's disease.
    PLoS One. 2019;14:e0222060.
    PubMed     Abstract available


  92. WOLOSZYNEK S, Mell JC, Zhao Z, Simpson G, et al
    Exploring thematic structure and predicted functionality of 16S rRNA amplicon data.
    PLoS One. 2019;14:e0219235.
    PubMed     Abstract available


  93. ABBAS M, Matta J, Le T, Bensmail H, et al
    Biomarker discovery in inflammatory bowel diseases using network-based feature selection.
    PLoS One. 2019;14:e0225382.
    PubMed     Abstract available


  94. KUBOTA M, Kakimoto K, Nakagawa T, Koubayashi E, et al
    Autophagy deficiency exacerbates colitis through excessive oxidative stress and MAPK signaling pathway activation.
    PLoS One. 2019;14:e0225066.
    PubMed     Abstract available


  95. COOPE A, Pascoal LB, Botezelli JD, da Silva FAR, et al
    ER stress activation in the intestinal mucosa but not in mesenteric adipose tissue is associated with inflammation in Crohn's disease patients.
    PLoS One. 2019;14:e0223105.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: